Ambra BioScience LLC - Lovidia
San Diego
About Ambra BioScience LLC - Lovidia
Ambra BioScience LLC - Lovidia is a proprietary Gut Sensory Modulation Technology Platform used to create medical meals and dietary supplements that address important health and wellness issues, like preserving a healthy weight and blood sugar levels. They were concerned with the hormones that the L cells in the lower gut normally release. GLP-1, PYY, and oxyntomodulin are released when the nutrients in food naturally stimulate the bitter, umami, and sweet taste receptors found on the luminal side of the L-cells. These hormones have an impact on mood, glucose regulation, inflammation, and the regulation of hunger and fullness.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.2M
- Last round: Series Unknown (Dec 2017)
- Website: ambrabio.com
- Phone: +1 (858) 914-4822
Industries & Categories
Biopharma, Clinical Trials, Health Care, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ambra-bioscience-llc-lovidia-138756 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.